Publication | Open Access
Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria
17
Citations
16
References
2020
Year
SRL can improve survival outcomes in LT patients with HCC exceeding the Hangzhou criteria.
| Year | Citations | |
|---|---|---|
Page 1
Page 1